Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-24

Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Ivermectin in Pediatric Dengue Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on pharmacokinetics and pharmacodynamics of ivermectin in pediatric dengue patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: Mahidol University | Conditions: Dengue Hemorrhagic Fever | Phase 2 | Status: COMPLETED